The overall safety profile appears favorable based on available data, though individual responses vary
[DOI] [PMC free article] [PubMed] [Google Scholar] 106.Ronnett GV, Kleman AM, Kim EK, Landree LE, Tu Y
I had been working on triple negative breast cancer for a number of years, looking at it from the angle of obesity, trying to understand why obesity drives triple negatives to become more aggressive
Elamipretide, a mitochondria-targeting peptide, emerges as a promising candidate in combating mitochondrial dysfunction-related disorders
This helps in proper cell growth and development, helps in protein synthesis and production of blood cells (red and white blood cells)
Support Our Work If this tool helps you, consider supporting it